Menu Back toBest Practices in Governance Meetings

DIA 2021 Global Annual Meeting

Best Practices in Governance Meetings

Session Chair(s)

Nathan Kreischer, MS, PMP

Nathan Kreischer, MS, PMP

  • Director, Global Project & Alliance Management
  • Merck & Co. Inc., United States
This session will discuss best practices and key success factors for enabling and maximizing the effectiveness of interactions with Governance boards. Governance structures and key elements will be examined and compared from multiple viewpoints including CRO, pharma, and biotech.
Learning Objective : Describe the governance structures and team interactions which occur in different sectors of the industry; Discuss key elements and best practices which maximize the effectiveness of the interactions and result in high-performance outcomes including trust and transparency, identification of key performance indicators, clear definition and communication of priorities, alignment between the strategy and execution, and unambiguous decision making.

Speaker(s)

Nathan Kreischer, MS, PMP

Best Practices in Governance: Big Pharma

Nathan Kreischer, MS, PMP

  • Director, Global Project & Alliance Management
  • Merck & Co. Inc., United States
Melissa Mauriber

Best Practices in Governance: Contract Research Organization (CRO)

Melissa Mauriber

  • VP, Clinical Operations Quality & Talent Development
  • Advanced Clinical, United States
Leann Frankel, MPH

Best Practices in Governance: Small Biotech

Leann Frankel, MPH

  • Strategic Sourcing Lead - Clinical Operations
  • Gates Medical Research Institute, United States